Literature DB >> 2873669

Cure of malignant lymphoma in dogs with peripheral blood stem cell transplantation.

F R Appelbaum, H J Deeg, R Storb, T C Graham, K Charrier, W Bensinger.   

Abstract

Twelve dogs with spontaneous malignant lymphoma in chemotherapy-induced remission were treated with total-body irradiation (TBI) and transplantation of autologous peripheral blood mononuclear cells collected following chemotherapy-induced expansion of the stem cell pool. Four animals (33%) died of transplant-related complications, five (41%) relapsed, and three (25%) are long-term disease-free survivors. Recovery to 1000 white cells/mm3 occurred by day 16 and dogs no longer required platelet transfusions by day 37. With the exception of delayed platelet recovery these results are virtually identical to those previously reported using autologous bone marrow transplantation for canine lymphoma. This study therefore suggests that autologous peripheral blood mononuclear cells collected following chemotherapy-induced expansion of the stem cell pool may offer a realistic alternative to autologous marrow transplantation in patients with malignant lymphoma for whom autologous marrow is not available.

Entities:  

Mesh:

Year:  1986        PMID: 2873669     DOI: 10.1097/00007890-198607000-00004

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

Review 1.  Tolerance induction for solid organ grafts with donor-derived hematopoietic reconstitution.

Authors:  K L Gandy
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization.

Authors:  S J Morrison; D E Wright; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

Review 3.  Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?

Authors:  Kristy L Richards; Steven E Suter
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

4.  Five decades of progress in haematopoietic cell transplantation based on the preclinical canine model.

Authors:  M Lupu; R Storb
Journal:  Vet Comp Oncol       Date:  2007-03       Impact factor: 2.613

5.  Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human Cancers.

Authors:  Melinda Mata; Stephen Gottschalk
Journal:  Mol Ther       Date:  2016-09       Impact factor: 11.454

Review 6.  Developments and translational relevance for the canine haematopoietic cell transplantation preclinical model.

Authors:  Scott S Graves; Rainer Storb
Journal:  Vet Comp Oncol       Date:  2020-05-26       Impact factor: 2.385

7.  Therapeutic doses of multipotent stromal cells from minimal adipose tissue.

Authors:  Nan Zhang; Marilyn A Dietrich; Mandi J Lopez
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

8.  Circulating hematopoietic progenitors in patients with primary lung cancer.

Authors:  E Shimizu; J N Mukai; Y Takaue; T Ogura
Journal:  Jpn J Cancer Res       Date:  1990-12

Review 9.  Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation.

Authors:  Scott S Graves; Rainer Storb
Journal:  Vet Med Sci       Date:  2021-08-14

10.  Granulocyte-colony-stimulating factor enhances the circulating hematopoietic progenitors in lung cancer patients treated with cisplatin-containing regimens.

Authors:  J Mukai; E Shimizu; T Ogura
Journal:  Jpn J Cancer Res       Date:  1992-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.